A one-site, two-state model for the binding of anions in photosystem II

Photosystem II membranes, dialyzed against a Cl(-)-free buffer to remove bound Cl-, lost about 65% of the control activity. A light-intensity study of the Cl(-)-free membranes showed that all PS II centers were able to evolve oxygen at about 35% of the control rate when measured in Cl(-)-free medium. The Cl(-)-depleted membranes were immediately (< 15 s) reactivated to 85-90% of the original activity by the addition of fairly high concentrations of Cl- (Kd = 0.5 mM), but both Cl- and the activity were promptly lost when the membranes immediately after reactivation were diluted in a Cl(-)-free medium. However, stabilization of Cl(-)-binding could be accomplished by prolonged incubation in the presence of Cl-. The transition to stable binding, followed using 36Cl-, occurred over several minutes. The stable binding was further characterized by a Kd of 20 microM and a t1/2 for dissociation of about 1h [Lindberg et al. (1993) Photosynth. Res. 38, 401-408]. The effects on S2 signals of removal of Cl- were studied using EPR. The depletion of Cl- was accompanied by a shift in intensity toward the g = 4.1 signal at the expense of the multiline signal. When Cl- or Br- but not F- was added to the depleted PS II membranes, the original distribution of the signals was immediately (< 30 s) restored. We propose that Cl(-)-binding responsible for high oxygen-evolution activity and normal EPR properties of the S2 state may occur either as high affinity (Kd = 20 microM) and slowly exchanging (t1/2 = 1 h), or as low affinity (Kd = 0.5 mM) and rapidly exchanging (t1/2 < 15 s). Our results suggest that Br- but not F- has a mode of binding similar to that of Cl-. The high-affinity state is the normal state of binding, but once Cl- has been removed, it will first rebind as low-affinity, rapidly exchanging followed by conversion into a high-affinity, slowly exchanging mode of binding.     

RSFM网络及其在信号滤波中的应用

介绍了一种适用于模式识别的新型神经网络模型--局部有监督特征映射（Reglonal Supervised Feature Mapping,RSFM）网络,描述了该网络的拓扑结构和学习算法,研究了网络的基本性能,最后将其应用到了信号滤波中.理论研究和仿真实验表明,该网络结构简单、算法简洁,收敛速度快、识别精度高,适用于需要大样本训练、随机干扰严重的复杂模式的分类与识别.     

锌(Ⅱ)-氨基酸配合物分子内配体间疏水作用

应用 p H电位滴定法研究了配合物 Zn( Aa) 2 [Aa-=L- val(缬氨酸根 ) ,L- phe(苯丙氨酸根 ) ,L- trp(色氨酸根 ) ,L- tyr(酪氨酸根 ) ]在水和 2 0 %、40 %及 60 %二氧六环 /水溶液中的稳定性 [t=2 5℃ ,c=0 .1 mol/L Na Cl O4]。配合物 Zn( Aa) 2 相对于母体配合物 Zn( Aa) + 稳定性用Δlog K=log KZn( Aa)Zn( Aa) 2 - log KZn Zn( Aa) 表示。结果表明 :与 L-丙氨酸 ( L- ala)配合物 Zn( L- ala) 2 相比 ,所有这些氨基酸配合物 Zn( Aa) 2 均具有相对较大的 Δlog K值 ,表明这些配合物分子内存在着额外的稳定化作用。这种稳定性化作用可能主要归因于配合物分子内氨基酸侧链之间的疏水作用 ,并且这种作用随着氨基酸侧链结构及溶剂极性变化而变化     

Models for the elastic deformation of honeycombs

A theoretical model has been developed for predicting the elastic constants of honeycombs based on the deformation of the honeycomb cells by flexure, stretching and hinging. This is an extension of earlier work based on flexure alone. The model has been used to derive expressions for the tensile moduli, shear moduli and Poisson's ratios. Examples are given of structures with a negative Poisson's ratio. It is shown how the properties can be tailored by varying the relative magnitudes of the force constants for the different deformation mechanisms. Off-axis elastic constants are also calculated and it is shown how the moduli and Poisson's ratios vary with applied loading direction. Depending on the geometry of the honeycomb the properties may be isotropie (for regular hexagons) or extremely anisotropic. Again, the degree of anisotropy is also affected by the relative magnitude of the force constants for the three deformation mechanisms.     

The investigation of 32P wire for catheter-based endovascular irradiation

The dose distribution from a 32P source has been measured and calculated in order to evaluate its application in endovascular irradiation. The source dimension was 27 mm in length and 0.3 mm in diameter and was embedded in the end of a Ni-Ti wire. Dose measurements were performed using radiochromic film in several specially designed tissue equivalent phantoms. Loevinger's point dose kernel was used for the calculation. The approximate dose rate at a radial distance of 1.5 mm from the center of the source was found to be 6.75 cGy/s per GBq (0.25 cGy/s per mCi), which allows the delivery of a therapeutic dose in a short time interval with a satisfactory homogeneity without stepping the source. However, the dose rate falls off almost exponentially along the radial distance. Therefore it may not be suitable for treating large diameter vessel from a centrally located source. The effect of a curved 32P wire source on the radial dose distribution was also investigated. The results showed that for a maximum bend of 180 degrees the dose rate was increased by as much as 20% along the inner radial distance but decreased by as much as 20% along the outer radial distance compared to the dose along a straight wire. However, for curvatures normally encountered in a clinical situation, the dose rate was changed less than 5%.     

Isolation of a pentraxin-like protein from rainbow trout serum

To investigate the outcome of Graves' thyrotoxicosis after antithyroid drug management, data from 81 patients, treated in Chang Gung Memorial Hospital at Taipei and Linkou from October 1981 to March 1990, were analyzed. The gender ratio of female to male was 59:22. The mean age of onset was 33.1 +/- 10.5(15-60) year-old. All the patients were treated with antithyroid drug (Thionamide group) for a duration of 11 to 63 months (mean +/- SD = 28.1 +/- 9.8 months). Forty of 81 patients (49.4%) were remained remission after up to 2 years of follow-up. Those patients relapse usually occurred within 2 years after discontinuation of treatment (34/41), and only one exceptional case relapsed after 3 years. Three conditions affected the relapse rate. Patients with larger goiter (grade II-III) and shorter duration of treatment (< 23 months) had a higher relapse rate than those-with smaller goiter (grade O-I) [29/46 vs. 12/35; chi 2 = 6.576, p = 0.010; p = 0.015 in stepwise logistic regression (LR)] and longer duration of treatment (> or = 23 months) (15/20 vs. 26/61; chi 2 = 6.316, p = 0.012; p = 0.020 in LR). Patients with higher pre-treated serum triiodothyronine (T3) level (T3 > or = 300 ng/dl) had a higher relapse rate than those with lower T3 level (T3 < 300 ng/dl) in univariate analysis (30/50 vs. 11/31, chi 2 = 4.601, p = 0.032), but no significant difference by LR (P = 0.094). Other clinical parameters including age, sex, past history, family history, thyroxine (T4) level, T3/T4 ratio, thyroid autoantibodies, staging of ophthalmopathy, responsiveness to thyrotropin-releasing hormone stimulation test at the end of treatment, and whether combined treatment with thyroxine had no significant difference between the relapse and remission groups. These data suggest: (a) patients with larger goiter (grade II-III had higher relapse rate; (b) most of the recurrent thyrotoxicosis patients relapsed within two years after drug withdrawal; (c) continuing treatment for more than twenty-three months produces better outcome; (d) patients with Graves' thyrotoxicosis should be followed up for at least three years after withdrawal of antithyroid drug.